header-left
Share to Facebook Share to Twitter Bookmark and Share
File #: 210654    Version: 0 Name:
Type: Resolution Status: ADOPTED
File created: 6/24/2021 In control: CITY COUNCIL
On agenda: Final action: 6/24/2021
Title: Recognizing Kenneth C. Frazier upon the occasion of his retirement as Chief Executive Officer of Merck & Co., Inc.
Sponsors: Councilmember Green, Councilmember Henon, Councilmember Bass, Councilmember Parker, Councilmember Squilla, Councilmember Domb
Attachments: 1. Signature21065400
Date Ver.Action ByActionResultTallyAction DetailsVideo
6/24/20210 CITY COUNCIL Introduced and Moved to Be Placed on This Week's Final Passage Calendar - Rules Suspended   Action details Not available
6/24/20210 CITY COUNCIL ADOPTED   Action details Not available
Title
Recognizing Kenneth C. Frazier upon the occasion of his retirement as Chief Executive Officer of Merck & Co., Inc.

Body
WHEREAS, Kenneth C. Frazier will be retiring as chairman and chief executive officer (CEO) of the multinational pharmaceutical company Merck & Co., Inc. effective June 30, 2021; and

WHEREAS, Mr. Frazier joined Merck in 1992 as vice president, general counsel and secretary of the Astra Merck group. He was appointed as vice president of public affairs in 1994, and then in 1997 he assumed the additional responsibilities of assistant general counsel for corporate staff. Mr. Frazier was promoted to vice president and deputy general counsel in January 1999. In December 1999, he became senior vice president and general counsel. In November 2006, he was promoted to executive vice president and general counsel. Mr. Frazier served as executive vice president and president, Global Human Health, from 2007 to 2010. He was named president of Merck in May 2010. Mr. Frazier became Merck's chief executive officer and a member of its board in January 2011. He became chairman of the board on December 1, 2011; and

WHEREAS, Under Ken's strong and highly principled leadership, Merck strengthened its commitment to the company's core values: scientific excellence, business integrity, patient focus, and respect for all people; and

WHEREAS, Ken's vision and courage to make difficult decisions within Merck, while steadfastly investing in research and development, have positioned Merck well for sustainable future growth, as they continue to deliver innovative lifesaving medicines and vaccines and create long-term value for shareholders and other stakeholders; and

WHEREAS, Ken's belief in the importance of a strong, values-based culture, and his ability to attract and retain the best talent, will stand as an enduring testament to his concern and care for the people whose skill and commitment will be critical to Merck's continued success; and

WHEREAS, These char...

Click here for full text